# Why Eli Lilly (LLY) moves

Every archived Eli Lilly (LLY) move, explained the day it happened, with sources.

Source: https://perplo.app/why/LLY

- **2026-09-15 · LLY (Eli Lilly) +2.83%** — Foundayo's 30% market share validates weight-loss lead https://perplo.app/why/LLY/2026-09-15.md
- **2026-08-20 · LLY (Eli Lilly) +4.60%** — Eli Lilly guidance shift sparks 4.9% surge https://perplo.app/why/LLY/2026-08-20.md
- **2026-08-19 · LLY (Eli Lilly) +5.19%** — Eli Lilly guidance shift sparks 4.9% surge https://perplo.app/why/LLY/2026-08-19.md
- **2026-08-11 · LLY (Eli Lilly) +4.22%** — Eli Lilly wins U.K. approval for Foundayo weight-loss pill https://perplo.app/why/LLY/2026-08-11.md
- **2026-08-10 · LLY (Eli Lilly) +3.91%** — UK approval unlocks new obesity market for Lilly https://perplo.app/why/LLY/2026-08-10.md
- **2026-08-06 · LLY (Eli Lilly) +3.99%** — Eli Lilly beats, raises 2026 outlook on GLP-1 surge https://perplo.app/why/LLY/2026-08-06.md
- **2026-08-05 · LLY (Eli Lilly) +4.74%** — Eli Lilly beats, raises 2026 outlook on GLP-1 surge https://perplo.app/why/LLY/2026-08-05.md